loading

Xeris Biopharma Holdings Inc (XERS) 最新ニュース

pulisher
May 22, 2026

XERS Technical Analysis | Trend, Signals & Chart Patterns | XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) - ChartMill

May 22, 2026
pulisher
May 19, 2026

What Xeris Biopharma Holdings (XERS)'s Profit Return and Higher 2026 Guidance Means For Shareholders - Sahm

May 19, 2026
pulisher
May 15, 2026

Xeris Biopharma Holdings, Inc. (XERS) Stock Price, News, Quote & History - Yahoo Finance

May 15, 2026
pulisher
May 15, 2026

Xeris Biopharma Quality Draws Market Attention Through Growth Signals - Kalkine Media

May 15, 2026
pulisher
May 15, 2026

Xeris Biopharma Holdings, Inc. (XERS) Latest Stock News & Headlines - Yahoo Finance

May 15, 2026
pulisher
May 15, 2026

Shareholders Will Be Pleased With The Quality of Xeris Biopharma Holdings' (NASDAQ:XERS) Earnings - simplywall.st

May 15, 2026
pulisher
May 14, 2026

Vanguard Group Inc. Buys 1,358,760 Shares of Xeris Biopharma Holdings, Inc. $XERS - MarketBeat

May 14, 2026
pulisher
May 12, 2026

TradingKey - TradingKey

May 12, 2026
pulisher
May 12, 2026

Xeris Biopharma (XERS) Stock Price, News & Analysis $XERS - MarketBeat

May 12, 2026
pulisher
May 11, 2026

Xeris Biopharma Q3 EPS Forecast Decreased by HC Wainwright - MarketBeat

May 11, 2026
pulisher
May 11, 2026

A Look At Xeris Biopharma Holdings (XERS) Valuation After Its Profit Turnaround And Guidance Hike - Sahm

May 11, 2026
pulisher
May 09, 2026

Xeris forecasts $380M-$390M 2026 revenue as Recorlev commercial expansion ramps in H2 - MSN

May 09, 2026
pulisher
May 09, 2026

Results: Xeris Biopharma Holdings, Inc. Confounded Analyst Expectations With A Surprise Profit - Yahoo Finance

May 09, 2026
pulisher
May 09, 2026

Number of shareholders of Xeris Biopharma Holdings, Inc. – DUS:2B30 - TradingView

May 09, 2026
pulisher
May 09, 2026

Xeris Biopharma Q1 Earnings Call Highlights - MarketBeat

May 09, 2026
pulisher
May 08, 2026

Q1 2026 Xeris Biopharma Holdings Inc Earnings Call Transcript - GuruFocus

May 08, 2026
pulisher
May 08, 2026

Xeris Biopharma Holdings, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 08, 2026
pulisher
May 08, 2026

Xeris Biopharma Holdings (XERS) Is Up 8.2% After Swing to Q1 ProfitabilityWhat's Changed - Yahoo Finance

May 08, 2026
pulisher
May 07, 2026

Xeris Biopharma Reports First Quarter 2026 Financial Results - BioSpace

May 07, 2026
pulisher
May 07, 2026

Xeris (XERS) Q1 2026 Earnings Call Transcript - The Globe and Mail

May 07, 2026
pulisher
May 07, 2026

Rekorlev-driven revenue lifts Xeris Biopharma (XERS) to Q1 2026 profitability - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Earnings call transcript: Xeris Biopharma Q1 2026 reports solid growth By Investing.com - Investing.com South Africa

May 07, 2026
pulisher
May 07, 2026

Xeris Biopharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

XERS: Q1 revenue jumped 43% year-over-year, prompting a raised full-year outlook to $380–$390 million - TradingView

May 07, 2026
pulisher
May 07, 2026

Xeris Biopharma (XERS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

May 07, 2026
pulisher
May 07, 2026

Xeris Biopharma (NASDAQ:XERS) Achieves First Profit, Beats Q1 Estimates with 95% Recorlev Surge - ChartMill

May 07, 2026
pulisher
May 07, 2026

Earnings Flash (XERS) Xeris Biopharma Holdings Posts Q1 EPS $0.01, vs. FactSet Est of $0.01 Loss per Share - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

Xeris Biopharma: Q1 Earnings Snapshot - Barchart.com

May 07, 2026
pulisher
May 07, 2026

Xeris Biopharma (XERS) surges with 38% Q1 revenue growth and profit - Stock Titan

May 07, 2026
pulisher
May 06, 2026

Xeris Pharmaceuticals Q1 2026 earnings preview - MSN

May 06, 2026
pulisher
May 02, 2026

Insider Sell Alert: Beth Hecht Sells 16,667 Shares of Xeris Biop - GuruFocus

May 02, 2026
pulisher
May 01, 2026

Insider Sell Alert: Beth Hecht Sells 16,667 Shares of Xeris Biopharma Holdings Inc (XERS) - GuruFocus

May 01, 2026
pulisher
May 01, 2026

Beth Hecht Sells 16,667 Shares of Xeris Biopharma (NASDAQ:XERS) Stock - MarketBeat

May 01, 2026
pulisher
May 01, 2026

Xeris Biopharma’s chief legal officer sells $103,805 in stock By Investing.com - Investing.com Canada

May 01, 2026
pulisher
May 01, 2026

Xeris Biopharma’s chief legal officer sells $103,805 in stock - Investing.com

May 01, 2026
pulisher
May 01, 2026

Xeris Biopharma (XERS) officer sells 16,667 shares under 10b5-1 plan - Stock Titan

May 01, 2026
pulisher
Apr 30, 2026

Xeris Biopharma (XERS) to Release Earnings on Thursday - MarketBeat

Apr 30, 2026
pulisher
Apr 28, 2026

Xeris Biopharma Reports Third Quarter 2024 Financial Results - Quantisnow

Apr 28, 2026
pulisher
Apr 27, 2026

Xeris Biopharma Holdings, Inc. (XERS) Hit a 52 Week High, Can the Run Continue? - MSN

Apr 27, 2026
pulisher
Apr 26, 2026

Xeris Biopharma expects full-year 2025 revenue above estimates - MSN

Apr 26, 2026
pulisher
Apr 24, 2026

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Apr 24, 2026
pulisher
Apr 23, 2026

Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026 - BioSpace

Apr 23, 2026
pulisher
Apr 23, 2026

Xeris Biopharma Holdings, Inc. ($XERS) CEO 2025 Pay Revealed - Quiver Quantitative

Apr 23, 2026
pulisher
Apr 23, 2026

[ARS] Xeris Biopharma Holdings, Inc. SEC Filing - Stock Titan

Apr 23, 2026
pulisher
Apr 23, 2026

Xeris Biopharma (NASDAQ: XERS) details 2026 votes on pay, board, auditor - Stock Titan

Apr 23, 2026
pulisher
Apr 23, 2026

Xeris (XERS) Year-Ahead Outlook | Q4 2025: EPS Exceeds ExpectationsDark Pool - Cổng thông tin điện tử Tỉnh Sơn La

Apr 23, 2026
$21.99
price up icon 1.38%
RDY RDY
$13.79
price up icon 1.42%
RGC RGC
$26.52
price down icon 1.89%
$157.31
price up icon 0.93%
$16.64
price down icon 0.32%
$562.55
price down icon 0.24%
大文字化:     |  ボリューム (24 時間):